Table 1. Cell lines characterization.
| Cell line | EBV latency | Malignant | Clumps | Virus source | In vitro transfection | Cell source |
|---|---|---|---|---|---|---|
| CBM1-Ral-STO | III | − | +++ | Rael | + | Human B-cell (cord blood) |
| CBC-JK2-STO | III | − | +++ | Jijoye | + | Human B-cell (cord blood) |
| Nad20 | III | − | +++ | B95–8 | + | Human B-cell (Adult Blood) |
| Rael | I | + | − | Tumor | − | Burkitt Lymphoma |
| Akata | I | + | − | Tumor | − | Burkitt Lymphoma |
| Mutu I cl.148 | I | + | − | Tumor | − | Burkitt Lymphoma |
| Mutu III cl.99 | III | + | ++ | Tumor | − | Burkitt Lymphoma |
| Raji | II-III | + | + | Tumor | − | Burkitt Lymphoma |
| Daudi | II-III | + | + | Tumor | − | Burkitt Lymphoma |